Immunic to participate in investor and scientific conferences in may

New york , april 26, 2023 /prnewswire/ -- immunic, inc. (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor and scientific conferences in may: may 2-4: aegis virtual conference. daniel vitt, ph.d.
IMUX Ratings Summary
IMUX Quant Ranking